Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Monteiro, I. Gonçalves, F. Calvário, A. Carvalho, R. Duarte (Vng, Porto, Portugal). Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists. Eur Respir J 2010; 36: Suppl. 54, 3047

Member's Comments

No comment yet.

Related content which might interest you: Adherence to national guidelines for interferon gamma release assay in diagnosis of mycobacterium tuberculosis Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Screening and monitoring of tuberculosis in patients on biologics treatment Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Follow up results for tuberculosis in patients who receive TNF antagonist treatment Source: Eur Respir J 2007; 30: Suppl. 51, 659s Year: 2007 Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis Source: Eur Respir J 2016; 48: 963-971 Year: 2016 Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area Source: International Congress 2015 – Screening strategies in TB Year: 2015 Screening and monitoring of TB infection in rheumatological patients on biologics therapy Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Are TB services in England adhering to new NICE guidelines on screening for latent TB? Source: International Congress 2017 – Migrants and screening Year: 2017 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014 Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB Source: Eur Respir J 2007; 30: Suppl. 51, 658s Year: 2007 Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study Source: Eur Respir J 2001; 18: 369-375 Year: 2001 Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006 Clinical effectiveness of recommended antibiotics in COVID19 pneumonias; assessing national referral centre guidance Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018